PATENT CLAIM ANALYSIS

Application Number: 15918397
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-03
Patent Classification: ["549", "427000"]

Abstract:
The compound according to the present embodiment is represented by the following formula (1): Q-L—CHR 2    (1) (wherein, Q is a non-cationic aliphatic group that does not contain nitrogen but contains oxy; L is a single bond or an aliphatic group containing no nitrogen; Rs are C 12 -C 24  aliphatic group, the same or different; and at least one R contains, in the main chain or side chain thereof, a linking group L R  selected from the group consisting of —C(═O)—O—, —O—C(═O)—, —O—C(═O)—O—, —S—C(═O)—, —C(═O)—S—, —C(═O)—NH—, and —NH—C(═O)—).

Claim (Index 19):
The lipid particle according to  claim 16 , further comprising a compound that regulates the expression of a nucleic acid in a cell.

Metadata:
- Claim Count in Document: 90.0
- Percentile: 90.0
- Lexical Diversity: 1.86486
- Patent Class: 549.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15407512', '14255637', '15320903', '15023052', '15846084']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7041126402266557
- 35 USC 102 Novelty (BERT): 0.4897148589599179
- Combined Prediction Score: 0.6826728620999819
- Mean Citation Score: 197.676952
- Max Citation Score: 203.61313
- Similarity Product: 141.71286541381122

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test